2021-2025年中国NK细胞疗法行业市场供需与战略研究报告

NK细胞疗法市场的企业竞争态势该报告涉及的主要国际市场参与者有ChipscreenBiosciences(China)、AffimedNV(Netherlands)、AltorBioScienceCorporation(USA)、InnatePharmaSA(France)、TakedaPharmaceutical(Japan)、SorrentoTherapeutics...

17.2做空，挂13.7平～

本周可能冲击10元，看戏

公告 [Amend] Statement of acquisition of beneficial ownership by individuals

发表于 2017-02-13 00:00   1129次浏览

公告 [Amend]General statement of acquisition of beneficial ownership

发表于 2015-10-24 06:45   1364次浏览

公告 Statement of changes in beneficial ownership of securities

发表于 2015-10-17 04:53   1177次浏览

公告 Quarterly report [Sections 13 or 15(d)]

发表于 2015-09-10 19:44   1156次浏览

公告 General statement of acquisition of beneficial ownership

发表于 2015-09-01 06:29   1205次浏览

公告 Statement of changes in beneficial ownership of securities

发表于 2015-08-26 04:31   1239次浏览

公告 Statement of changes in beneficial ownership of securities

发表于 2015-08-26 04:31   1327次浏览

公告 Initial statement of beneficial ownership of securities

发表于 2015-08-12 06:52   1380次浏览

公告 Statement of changes in beneficial ownership of securities

发表于 2015-08-06 08:09   1182次浏览

公告 Notice of Exempt Offering of Securities, item 06b

发表于 2015-08-06 05:08   1282次浏览

公告 Current report, items 5.03 and 9.01

发表于 2015-08-05 03:05   1636次浏览

公告 Initial statement of beneficial ownership of securities

发表于 2015-07-29 04:51   1392次浏览

公告 Registration adding securities to prior Form S-1 registration [Rule 462(b)]

发表于 2015-07-29 04:51   1633次浏览

公告 Initial statement of beneficial ownership of securities

发表于 2015-07-29 04:51   1289次浏览